GENE ONLINE|News &
Opinion
Blog

2025-11-28|

NEK7 Identified as Key Regulator of Mitochondrial Function in Preventing Liver Fibrosis

by GOAI
Share To

Researchers have identified a critical connection between the kinase NEK7 and the succinate dehydrogenase complex subunit B (SDHB) in regulating mitochondrial respiratory chain electron transport, which plays a key role in preventing liver fibrosis. The findings highlight NEK7’s involvement in maintaining mitochondrial function and its potential impact on liver health. This discovery provides new insights into the mechanisms underlying liver fibrosis and may inform future therapeutic approaches.

The study demonstrates that NEK7 interacts with SDHB to ensure proper mitochondrial respiratory chain activity, which is essential for cellular energy production and metabolic balance. Disruptions in this process are linked to the development of liver fibrosis, a condition characterized by excessive scarring of liver tissue due to chronic injury or inflammation. By identifying this molecular interaction, researchers aim to better understand how imbalances in mitochondrial function contribute to fibrotic diseases and explore potential interventions targeting this pathway.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top